TrialBritish journal of cancer1998

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

P Möller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.